Lee, 7,019 patient budesonide prophylaxis study: 33% fewer cases [p=0.1] https://c19p.org/lee2
copied to clipboard
Association Between Inhaled Corticosteroid Use and the Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Nationwide Population-based Study in South Korea
et al., Research Square, doi:10.21203/rs.3.rs-72221/v1 (Preprint)
Retrospective 44,968 patients in South Korea, 7,019 on inhaled corticosteroids, showing no statistically significant differences in COVID-19 cases.
|
risk of case, 32.6% lower, RR 0.67, p = 0.10, treatment 19 of 1,674 (1.1%), control 95 of 5,345 (1.8%), NNT 156, adjusted per study, odds ratio converted to relative risk, multivariate.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Lee et al., 9/9/2021, retrospective, South Korea, Asia, preprint, 5 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.